The New York Proton Center in East Harlem is the first and only proton therapy center in New York State, but often brings its ...
A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...
Un aperçu des principales causes de décès en Amérique, basé sur les données de mortalité du CDC, et ce qui les provoque.
Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...
1d
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...
A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...
Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...
Au-delà de sa mobilisation aux côtés d'Odysséa, le Crédit Agricole agit tout au long de l'année pour faire reculer le cancer.
A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...
PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results